{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:29:11Z","timestamp":1793140151422,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1197652"],"award-info":[{"award-number":["APP1197652"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1107043"],"award-info":[{"award-number":["APP1107043"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001801","name":"University of Western Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001111","name":"Cancer Australia","doi-asserted-by":"publisher","award":["APP1163065"],"award-info":[{"award-number":["APP1163065"]}],"id":[{"id":"10.13039\/501100001111","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.adro.2022.101013","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T23:24:34Z","timestamp":1658359474000},"page":"101013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Effects of Photon Radiation on DNA Damage, Cell Proliferation, Cell Survival, and Apoptosis of Murine and Human Mesothelioma Cell Lines"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3615-3618","authenticated-orcid":false,"given":"Synat","family":"Keam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly M.","family":"MacKinnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"D'Alonzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suki","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin A.","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna K.","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5339-5374","authenticated-orcid":false,"given":"Alistair M.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2022.101013_bib0001","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1183\/16000617.0063-2016","article-title":"Malignant pleural mesothelioma: An update on investigation, diagnosis and treatment","volume":"25","author":"Bibby","year":"2016","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.adro.2022.101013_bib0003","doi-asserted-by":"crossref","first-page":"235","DOI":"10.21037\/atm.2017.03.97","article-title":"Overview of treatment related complications in malignant pleural mesothelioma","volume":"5","author":"Murphy","year":"2017","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.adro.2022.101013_bib0004","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2022.101013_bib0005","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","article-title":"First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): A multicentre, randomised, open-label, phase 3 trial","volume":"397","author":"Baas","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.adro.2022.101013_bib0006","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","article-title":"Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): A randomised, controlled, open-label, phase 3 trial","volume":"387","author":"Zalcman","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.adro.2022.101013_bib0007","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jtho.2019.03.030","volume":"14","author":"Gomez","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.adro.2022.101013_bib0008","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1245\/s10434-006-9127-4","article-title":"Radiation-induced cellular DNA damage repair response enhances viral gene therapy efficacy in the treatment of malignant pleural mesothelioma","volume":"14","author":"Adusumilli","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.adro.2022.101013_bib0009","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/antiox5030022","article-title":"Protection against radiotherapy-induced toxicity","volume":"5","author":"Hall","year":"2016","journal-title":"Antioxidants"},{"key":"10.1016\/j.adro.2022.101013_bib0010","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.21037\/tlcr-20-583","article-title":"Controversies in the role of radiotherapy in pleural mesothelioma","volume":"10","author":"Hanna","year":"2021","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.adro.2022.101013_bib0011","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1158\/1078-0432.728.11.2","article-title":"Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer","volume":"11","author":"Demaria","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.adro.2022.101013_bib0012","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1158\/1078-0432.CCR-09-0265","article-title":"Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti\u2013CTLA-4 antibody","volume":"15","author":"Dewan","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.adro.2022.101013_bib0013","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ijrobp.2012.12.025","article-title":"Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas","volume":"86","author":"Zeng","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2022.101013_bib0014","doi-asserted-by":"crossref","first-page":"e1169","DOI":"10.1002\/cti2.1169","article-title":"Enhancing the efficacy of immunotherapy using radiotherapy","volume":"9","author":"Keam","year":"2020","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.adro.2022.101013_bib0015","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fphar.2018.00185","article-title":"Combining immunotherapy and radiotherapy for cancer treatment: Current challenges and future directions","volume":"9","author":"Wang","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.adro.2022.101013_bib0016","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1158\/1078-0432.CCR-14-2824","article-title":"Ablative tumor radiation can change the tumor immune cell microenvironment to induce durable complete remissions","volume":"21","author":"Filatenkov","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.adro.2022.101013_bib0017","doi-asserted-by":"crossref","first-page":"558","DOI":"10.4049\/jimmunol.1200563","article-title":"Radiotherapy promotes tumor-specific effector CD8+ T cells via dendritic cell activation","volume":"189","author":"Gupta","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.adro.2022.101013_bib0018","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI67313","article-title":"Irradiation and anti\u2013PD-L1 treatment synergistically promote antitumor immunity in mice","volume":"124","author":"Deng","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.adro.2022.101013_bib0019","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3390\/cancers12010121","article-title":"Influence of radiotherapy fractionation schedule on the tumor vascular microenvironment in prostate and lung cancer models","volume":"12","author":"Cl\u00e9ment-Colmou","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.adro.2022.101013_bib0020","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1667\/RR3116.1","article-title":"Ablative hypofractionated radiotherapy normalizes tumor vasculature in lewis lung carcinoma mice model","volume":"179","author":"Lan","year":"2013","journal-title":"Radiat Res"},{"key":"10.1016\/j.adro.2022.101013_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2019.05.005","article-title":"Tumor vasculature remodeling by radiation therapy increases doxorubicin distribution and efficacy","volume":"457","author":"Potiron","year":"2019","journal-title":"Cancer Lett"},{"key":"10.1016\/j.adro.2022.101013_bib0022","doi-asserted-by":"crossref","first-page":"e84076","DOI":"10.1371\/journal.pone.0084076","article-title":"Improved functionality of the vasculature during conventionally fractionated radiation therapy of prostate cancer","volume":"8","author":"Potiron","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.adro.2022.101013_bib0023","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920965853","article-title":"Hypo-fractionation radiotherapy normalizes tumor vasculature in non-small cell lung cancer xenografts through the p-STAT3\/HIF-1 alpha signaling pathway","volume":"12","author":"Tong","year":"2020","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.adro.2022.101013_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.87415","article-title":"Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer","volume":"1","author":"Herter-Sprie","year":"2016","journal-title":"JCI insight"},{"key":"10.1016\/j.adro.2022.101013_bib0025","doi-asserted-by":"crossref","first-page":"e92572","DOI":"10.1371\/journal.pone.0092572","article-title":"Radiotherapy-induced anti-tumor immunity contributes to the therapeutic efficacy of irradiation and can be augmented by CTLA-4 blockade in a mouse model","volume":"9","author":"Yoshimoto","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.adro.2022.101013_bib0026","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S1470-2045(21)00149-2","article-title":"Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: A single-centre, randomised phase 2 trial","volume":"22","author":"Altorki","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2022.101013_bib0027","doi-asserted-by":"crossref","first-page":"e28780","DOI":"10.4161\/onci.28780","article-title":"Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy","volume":"3","author":"Grimaldi","year":"2014","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.adro.2022.101013_bib0028","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1056\/NEJMoa1112824","article-title":"Immunologic correlates of the abscopal effect in a patient with melanoma","volume":"366","author":"Postow","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.adro.2022.101013_bib0029","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa1809697","article-title":"Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC","volume":"379","author":"Antonia","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.adro.2022.101013_bib0030","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S1470-2045(17)30380-7","article-title":"Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: A secondary analysis of the KEYNOTE-001 phase 1 trial","volume":"18","author":"Shaverdian","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2022.101013_bib0031","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1001\/jamaoncol.2019.1478","article-title":"Effect of pembrolizumab after stereotactic body radiotherapy vs pembrolizumab alone on tumor response in patients with advanced non\u2013small cell lung cancer: Results of the PEMBRO-RT phase 2 randomized clinical trial","volume":"5","author":"Theelen","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.adro.2022.101013_bib0032","doi-asserted-by":"crossref","first-page":"12468","DOI":"10.18632\/oncotarget.3487","article-title":"Targeting the inhibitory receptor CTLA-4 on T cells increased abscopal effects in murine mesothelioma model","volume":"6","author":"Wu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.adro.2022.101013_bib0033","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12890-021-01513-7","article-title":"Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma","volume":"21","author":"Gray","year":"2021","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.adro.2022.101013_bib0034","doi-asserted-by":"crossref","first-page":"212","DOI":"10.21037\/tlcr.2017.04.01","article-title":"Immunotherapy and radiation therapy for malignant pleural mesothelioma","volume":"6","author":"Alley","year":"2017","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.adro.2022.101013_bib0035","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002038","article-title":"Radiation dose and fraction in immunotherapy: One-size regimen does not fit all settings, so how does one choose?","volume":"9","author":"Demaria","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.adro.2022.101013_bib0036","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s13104-018-3438-y","article-title":"Effects of ionizing radiation on the viability and proliferative behavior of the human glioblastoma T98G cell line","volume":"11","author":"Murad","year":"2018","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.adro.2022.101013_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2018.101084","article-title":"ROS and the DNA damage response in cancer","volume":"25","author":"Srinivas","year":"2019","journal-title":"Redox Biology"},{"key":"10.1016\/j.adro.2022.101013_bib0038","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/ijms17010102","article-title":"Cellular pathways in response to ionizing radiation and their targetability for tumor radiosensitization","volume":"17","author":"Maier","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.adro.2022.101013_bib0039","doi-asserted-by":"crossref","first-page":"e532","DOI":"10.1016\/S1470-2045(17)30459-X","article-title":"Radiotherapy for the treatment of malignant pleural mesothelioma","volume":"18","author":"de Perrot","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2022.101013_bib0040","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0277-5379(89)90266-6","article-title":"Radiation sensitivity of human lung cancer cell lines","volume":"25","author":"Carmichael","year":"1989","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/j.adro.2022.101013_bib0041","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.4049\/jimmunol.171.10.5051","article-title":"IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature: A novel mechanism for IL-2","volume":"171","author":"Jackaman","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.adro.2022.101013_bib0042","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/ijc.2910520609","article-title":"Establishment of a murine model of malignant mesothelioma","volume":"52","author":"Davis","year":"1992","journal-title":"Int J Cancer"},{"key":"10.1016\/j.adro.2022.101013_bib0043","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/BF03178355","article-title":"The use of the linear quadratic model in radiotherapy: A review","volume":"24","author":"Jones","year":"2001","journal-title":"Australas Phys Eng Sci Med"},{"key":"10.1016\/j.adro.2022.101013_bib0044","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.clon.2015.02.008","article-title":"Treatment of breast and prostate cancer by hypofractionated radiotherapy: Potential risks and benefits","volume":"27","author":"Ray","year":"2015","journal-title":"Clin Oncol"},{"key":"10.1016\/j.adro.2022.101013_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146021","article-title":"Dose-response analysis using R","volume":"10","author":"Ritz","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.adro.2022.101013_bib0046","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1634\/theoncologist.2010-0185","article-title":"What is the role of radiotherapy in malignant pleural mesothelioma?","volume":"16","author":"Price","year":"2011","journal-title":"The Oncologist"},{"key":"10.1016\/j.adro.2022.101013_bib0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-019-1344-7","article-title":"Development of a high-throughput \u03b3-H2AX assay based on imaging flow cytometry","volume":"14","author":"Lee","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2022.101013_bib0048","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/leu.2010.6","article-title":"\u03b3H2AX: A sensitive molecular marker of DNA damage and repair","volume":"24","author":"Mah","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.adro.2022.101013_bib0049","first-page":"42","article-title":"Effects of different doses of X\u2011ray irradiation on cell apoptosis, cell cycle, DNA damage repair and glycolysis in HeLa cells","volume":"17","author":"Zhao","year":"2019","journal-title":"Oncol Lett"},{"key":"10.1016\/j.adro.2022.101013_bib0050","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1269\/jrr.0628","article-title":"Flow cytometric analysis of phosphorylated histone H2AX following exposure to ionizing radiation in human microvascular endothelial cells","volume":"47","author":"Kataoka","year":"2006","journal-title":"J Radiat Res (Tokyo)"},{"key":"10.1016\/j.adro.2022.101013_bib0051","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/0955300032000093128","article-title":"Expression of phosphorylated histone H2AX in cultured cell lines following exposure to X-rays","volume":"79","author":"MacPhail","year":"2003","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.adro.2022.101013_bib0052","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1590\/S1415-475738420150019","article-title":"Ionizing radiation-induced DNA injury and damage detection in patients with breast cancer","volume":"38","author":"Borrego-Soto","year":"2015","journal-title":"Genet Mol Biol"},{"key":"10.1016\/j.adro.2022.101013_bib0053","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fmolb.2014.00024","article-title":"Biological response of cancer cells to radiation treatment","volume":"1","author":"Baskar","year":"2014","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.adro.2022.101013_bib0054","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1667\/RR1661.1","article-title":"Cell cycle dependence of ionizing radiation-induced DNA deletions and antioxidant radioprotection in Saccharomyces cerevisiae","volume":"173","author":"Hafer","year":"2010","journal-title":"Radiat Res"},{"key":"10.1016\/j.adro.2022.101013_bib0055","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1080\/09553002.2018.1440094","article-title":"Radiation-induced G2\/M arrest rarely occurred in glioblastoma stem-like cells","volume":"94","author":"Liu","year":"2018","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.adro.2022.101013_bib0056","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/sj.cdd.4400402","article-title":"Irradiation induces G2\/M cell cycle arrest and apoptosis in p53-deficient lymphoblastic leukemia cells without affecting Bcl-2 and Bax expression","volume":"5","author":"Strasser-Wozak","year":"1998","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.adro.2022.101013_bib0057","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nrc2169","article-title":"CDC25 phosphatases in cancer cells: Key players? Good targets?","volume":"7","author":"Boutros","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.adro.2022.101013_bib0058","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/excr.2000.4872","article-title":"Centrosomal and cytoplasmic Cdc2\/cyclin B1 activation precedes nuclear mitotic events","volume":"257","author":"De Souza","year":"2000","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.adro.2022.101013_bib0059","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev.biochem.73.011303.073723","article-title":"Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints","volume":"73","author":"Sancar","year":"2004","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.adro.2022.101013_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41420-020-00301-2","article-title":"BECN1 promotes radiation-induced G2\/M arrest through regulation CDK1 activity: A potential role for autophagy in G2\/M checkpoint","volume":"6","author":"Huang","year":"2020","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.adro.2022.101013_bib0061","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.3892\/or.2016.4630","article-title":"Radiosensitization effect of Huaier on breast cancer cells","volume":"35","author":"Ding","year":"2016","journal-title":"Oncol Rep"},{"key":"10.1016\/j.adro.2022.101013_bib0062","first-page":"3718","article-title":"Cell cycle arrests and radiosensitivity of human tumor cell lines: Dependence on wild-type p53 for radiosensitivity","volume":"54","author":"McIlwrath","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.adro.2022.101013_bib0063","doi-asserted-by":"crossref","first-page":"7144","DOI":"10.1158\/0008-5472.CAN-04-1433","article-title":"Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines","volume":"64","author":"Ban\u00e1th","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.adro.2022.101013_bib0064","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ijrobp.2003.09.028","article-title":"Phosphorylation of histone H2AX as a measure of radiosensitivity","volume":"58","author":"Olive","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2022.101013_bib0065","doi-asserted-by":"crossref","first-page":"e79541","DOI":"10.1371\/journal.pone.0079541","article-title":"Use of the \u03b3-H2AX assay to investigate DNA repair dynamics following multiple radiation exposures","volume":"8","author":"Mariotti","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.adro.2022.101013_bib0066","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1002\/ijc.25953","article-title":"Prolonged expression of the \u03b3-H2AX DNA repair biomarker correlates with excess acute and chronic toxicity from radiotherapy treatment","volume":"129","author":"Bourton","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.adro.2022.101013_bib0067","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/cdd.2016.65","article-title":"Impaired DNA double-strand break repair contributes to the age-associated rise of genomic instability in humans","volume":"23","author":"Li","year":"2016","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.adro.2022.101013_bib0068","first-page":"66","article-title":"Impaired NHEJ function in multiple myeloma","volume":"660","author":"Yang","year":"2009","journal-title":"Mutat Res"},{"key":"10.1016\/j.adro.2022.101013_bib0069","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3171\/jns.2003.98.2.0378","article-title":"Molecular response of human glioblastoma multiforme cells to ionizing radiation: Cell cycle arrest, modulation of cyclin-dependent kinase inhibitors, and autophagy","volume":"98","author":"Yao","year":"2003","journal-title":"J Neurosurg"},{"key":"10.1016\/j.adro.2022.101013_bib0073","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fcell.2020.00041","article-title":"Molecular mechanisms of radiation-induced cancer cell death: A primer","volume":"8","author":"Sia","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.adro.2022.101013_bib0070","first-page":"548","article-title":"Low-dose irradiation inhibits proliferation of the p53null type human prostate cancer cells through the ATM\/p21 pathway","volume":"41","author":"Li","year":"2018","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.adro.2022.101013_bib0071","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/sj.onc.1206138","article-title":"Apoptosis or growth arrest: Modulation of the cellular response to p53 by proliferative signals","volume":"22","author":"Heinrichs","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.adro.2022.101013_bib0072","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2184.2003.00267.x","article-title":"Cell cycle and apoptosis","volume":"36","author":"Vermeulen","year":"2003","journal-title":"Cell Prolif"},{"key":"10.1016\/j.adro.2022.101013_bib0074","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1038\/onc.2012.556","article-title":"Various modes of cell death induced by DNA damage","volume":"32","author":"Surova","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.adro.2022.101013_bib0075","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/02841869609109921","article-title":"Radiosensitivity of mesothelioma cell lines","volume":"35","author":"H\u00e4kkinenm","year":"1996","journal-title":"Acta Oncol"},{"key":"10.1016\/j.adro.2022.101013_bib0076","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.tranon.2018.06.008","article-title":"PSP1, a phosphatidylserine-recognizing peptide, is useful for visualizing radiation-induced apoptosis in colorectal cancer in vitro and in vivo","volume":"11","author":"Bae","year":"2018","journal-title":"Transl Oncol"},{"key":"10.1016\/j.adro.2022.101013_bib0077","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/sj.cgt.7700649","article-title":"Increased radiation-induced apoptosis and altered cell cycle progression of human lung cancer cell lines by antisense oligodeoxynucleotides targeting p53 and p21 WAF1\/CIP1","volume":"10","author":"Sak","year":"2003","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.adro.2022.101013_bib0078","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/09553000210148903","article-title":"Radiation-induced apoptosis in human non-small-cell lung cancer cell lines is secondary to cell-cycle progression beyond the G2-phase checkpoint","volume":"78","author":"Stuschke","year":"2002","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.adro.2022.101013_bib0079","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1158\/1078-0432.CCR-20-4037","article-title":"Alterations in BAP1 are associated with cisplatin resistance through inhibition of apoptosis in malignant pleural mesothelioma","volume":"27","author":"Oehl","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.adro.2022.101013_bib0080","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ng.2323","article-title":"BAP1 loss defines a new class of renal cell carcinoma","volume":"44","author":"Pe\u00f1a-Llopis","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.adro.2022.101013_bib0081","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S1470-2045(20)30462-9","article-title":"Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): A multicentre, single-arm, phase 2 trial with a safety run-in","volume":"21","author":"Nowak","year":"2020","journal-title":"Lancet Oncol"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109422001191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109422001191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:22Z","timestamp":1778889622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109422001191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":80,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S2452109422001191"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2022.101013","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Photon Radiation on DNA Damage, Cell Proliferation, Cell Survival, and Apoptosis of Murine and Human Mesothelioma Cell Lines","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2022.101013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101013"}}